Latest Industry Insights
Industry Insight
Detecting Mutations With Liquid Biopsies
Here we summarize the webinar that was hosted by Monika Seidel Ph.D., in which she discussed detecting mutations with liquid biopsies in cancer diagnostics.
Industry Insight
Meeting Renewed Regulatory Focus on Gene Therapy Safety Standards
In this industry insights piece, we explore how gene therapies represent a rapidly growing new paradigm — both therapeutically and with respect to how they are managed within the larger scope of healthcare — and how this has wide-ranging impacts on several key areas, including regulation.
Industry Insight
Eliciting the Hormetic Effect: The Importance of Plant Alkaloids for Treatment of Inflammation
Today, plant alkaloids are attracting notice as novel therapies for conditions involving inflammation, such as metabolic syndrome, autoimmune disease and even for aging, which are often characterized by chronic, low-grade over-activation of the immune system. This piece takes a closer look at the need for novel treatments and the best uses for plant alkaloids.
Industry Insight
PCR: The "Workhorse" Technology
Technology Networks spoke with Dr Jan Hellemans, CTO and co-founder of CRO Biogazelle, as well as co-author of the MIQE guidelines, to learn why PCR-based technologies are the "workhorse" technologies for the company.
Industry Insight
A "One-and-Done" Treatment To Protect Against Heart Disease?
Verve Therapeutics is utilizing two of the biggest scientific breakthroughs of the twenty-first century – DNA sequencing and genome editing – to design a one-time treatment for lowering cholesterol.
Industry Insight
The Impact of Emerging SARS-CoV-2 Variants on Diagnostic Testing
The emergence of SARS-CoV-2 variants has led to concerns over the potential impacts there could be on the effectiveness of diagnostics and other countermeasures. Here, we look at the effects the B.1.1.7 variant may have on diagnostic tests.
Industry Insight
Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
Technology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.
Industry Insight
3 Major Trends for Cardiac Drug Discovery in 2020
Without a doubt, we will remember 2020 as the year of the COVID-19 pandemic. For the biopharma and healthcare sectors, the focus was firmly on the rapid development of diagnostics, therapies and vaccines that could be produced at scale. But under the radar, other life science fields have been powering on – among them, the cardiac field.
Industry Insight
How Will Genome UK Securely Handle 150 Petabases of Genomic Data?
Genomic data company PetaGene recently sounded a warning that Genome UK, the UK government’s recently announced genomic healthcare strategy, needs to address important data handling challenges to maintain public trust. To find out more, Technology Networks spoke to PetaGene’s co-founder and chief commercial officer, Vaughan Wittorff, PhD, and co-founder and chief executive officer, Dan Greenfield, PhD.
Industry Insight
Capturing the Transcriptome and the Epigenome Simultaneously in Single Cells
How do we take our understanding of the different stages of the omics cascade to the next level? We analyze them simultaneously. With the recent launch of its Chromium Single Cell Multiome ATAC + Gene Expression solution, 10x Genomics is making advances towards that goal. Technology Networks spoke with Ben Hindson to learn more.
Advertisement